Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial

Table 1

BARI 2D demographics and clinical history by sex.

Demographic/clinical history	Female; ()	Male; ()	value
Age at entry (years), mean ± SD	62.9 ± 9.3	62.2 ± 8.7	0.08
Race ethnicity			<0.001
White, non-Hispanic	55.5%	69.8%
Black or African-American, non-Hispanic	27.7%	12.4%
Hispanic	13.0%	12.5%
Asian and others	3.8%	5.3%
Region and country			<0.001
United States and Canada	74.9%	79.1%
México and Brazil	22.1%	17.7%
Czech Republic& Austria	3.1%	3.3%
Education level			<0.001
<High school	46.1%	33.0%
High school	53.9%	67.0%
BMI (kg/m^2), mean ± SD	32.9 ± 6.9	31.3 ± 5.4	<0.001
Diabetes duration (years), mean ± SD	12.2 ± 9.6	9.7 ± 8.1	<0.001
History of hypertension	87.2%	80.4%	<0.001
History of hypercholesterolemia	82.9%	81.4%	0.4
History of MI	27.9%	33.6%	0.007
History of CHF	7.8%	6.0%	0.1
CABG prior to randomization	4.5%	7.2%	0.02
PCI prior to randomization	20.1%	19.4%	0.7
Cerebrovascular Accident	11.0%	9.3%	0.2
Physical Activity			<0.001
Sedentary	28.2%	19.3%
Mild to moderate	69.6%	77.4%
Strenuous	2.2%	3.3%
Cigarette smoking			<0.001
Never smoked	51.9%	25.4%
Current smoker	9.8%	13.4%
Self-rated health			<0.001
Excellent to good	46.8%	56.4%
Fair to poor	53.3%	43.6%
Mean HbA1C (%)	8.0 ± 1.7	7.5 ± 1.6	<0.001
Mean blood pressure (mm Hg)
Systolic (mm Hg)	134.8 ± 22.6	130.4 ± 18.7	<0.001
Diastolic (mm Hg)	73.8 ± 12.5	74.9 ± 10.6	0.04
Mean LDL cholesterol (mg/dL)	102.9 ± 34.8	93.5 ± 32.2	<0.001

MI = myocardial infarction; CHF = congestive heart failure.